Sign In
Buy GILD
$125.05
+0.180 (+0.144%)
At Close: Jun 23, 2026
Markets Haven't Changed. These 2 Cheap Dividends Still Rule
10:50am, Wednesday, 01'st Apr 2026
Fear is up, markets are down—and we contrarians know that times like these are when we go shopping for cheap dividends.
Gilead Sciences (GILD) Rises Yet Lags Behind Market: Some Facts Worth Knowing
06:50pm, Tuesday, 31'st Mar 2026
In the latest trading session, Gilead Sciences (GILD) closed at $139.37, marking a +2.22% move from the previous day.
Gilead Sciences, Inc. (GILD) M&A Call Transcript
02:12pm, Tuesday, 31'st Mar 2026
Gilead Sciences, Inc. (GILD) M&A Call Transcript
Boston Common Asset Management LLC Sells 15,833 Shares of Gilead Sciences, Inc. $GILD
04:34am, Tuesday, 31'st Mar 2026
Boston Common Asset Management LLC decreased its holdings in Gilead Sciences, Inc. (NASDAQ: GILD) by 12.2% during the undefined quarter, according to the company in its most recent filing with the SEC
Beacon Investment Advisory Services Inc. Buys 10,449 Shares of Gilead Sciences, Inc. $GILD
03:35am, Monday, 30'th Mar 2026
Beacon Investment Advisory Services Inc. lifted its stake in Gilead Sciences, Inc. (NASDAQ: GILD) by 10.3% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. T
Why Gilead Sciences (GILD) Dipped More Than Broader Market Today
07:00pm, Friday, 27'th Mar 2026
Gilead Sciences (GILD) closed the most recent trading day at $134.25, moving 1.92% from the previous trading session.
Here's Why Gilead Sciences (GILD) is a Strong Value Stock
10:41am, Friday, 27'th Mar 2026
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Is Gilead (GILD) a Buy as Wall Street Analysts Look Optimistic?
10:32am, Friday, 27'th Mar 2026
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analy
Can Gilead's Recent Acquisitions Strengthen Its Long-Term Growth Outlook?
09:51am, Friday, 27'th Mar 2026
Gilead doubles down on acquisitions, adding immunology and CAR-T assets to diversify beyond HIV and strengthen its oncology pipeline.
Czech National Bank Buys 12,009 Shares of Gilead Sciences, Inc. $GILD
04:43am, Thursday, 26'th Mar 2026
Czech National Bank lifted its stake in shares of Gilead Sciences, Inc. (NASDAQ: GILD) by 3.8% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 327,149 shares of
Assenagon Asset Management S.A. Has $32.78 Million Stock Position in Gilead Sciences, Inc. $GILD
03:04am, Thursday, 26'th Mar 2026
Assenagon Asset Management S.A. lowered its stake in shares of Gilead Sciences, Inc. (NASDAQ: GILD) by 92.3% during the fourth quarter, according to the company in its most recent filing with the Secu
Gilead Strengthens Inflammation Portfolio With Ouro Medicines Deal
04:07pm, Tuesday, 24'th Mar 2026
GILD expands into autoimmune therapies with an acquisition deal with Ouro Medicines, adding OM336 and advancing its push into next-gen immunology platforms.
E. Ohman J or Asset Management AB Increases Stock Holdings in Gilead Sciences, Inc. $GILD
02:46pm, Tuesday, 24'th Mar 2026
E. Ohman J or Asset Management AB raised its position in Gilead Sciences, Inc. (NASDAQ: GILD) by 22.0% in the undefined quarter, according to the company in its most recent filing with the Securities
Gilead Sciences to acquire Ouro Medicines, expanding autoimmune therapy portfolio
10:31am, Tuesday, 24'th Mar 2026
Gilead Sciences Inc (NASDAQ:GILD, XETRA:GIS) announced it has entered into a definitive agreement to acquire Ouro Medicines, a privately held biotech company developing T cell engager therapies for au
Stock Market Today (LIVE): Market Rally Fizzles as Oil Rebounds; Smithfield Foods Hams It Up
09:31am, Tuesday, 24'th Mar 2026
Top insights from the latest market news from Tuesday, March 24, from The Motley Fool analysts on Team Rule Breakers and Team Hidden Gems.
